Arkolith/Insider Trading/PHAS/Form 4

New Enterprise Associates 13 LP

10% OwnerPhaseBio Pharmaceuticals Inc (PHAS) · full profile →Form 4 · filed Oct 26, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$268K
Net Open-Market Flow
-$268K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 25, 2022Sell(S)1.8M$0.15$268K4.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-054647) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML